Wednesday, February 17, 2010

Reduce Total Cost & Improve Diabetes Medication Adherence through Value-Based Plan Design

A CVS-Caremark study released in the American Journal of Pharmacy Benefits shows that eliminating or reducing co-pays for diabetes medication can improve medication adherence. The study compared 20,000 participants in a value-based benefit design to over 190,000 participants in a standard 3-tier co-pay benefit design.

A separate study released by the New England Healthcare Institute shows that not taking medications properly leads to higher costs, more hospitalizations, and poorer health, adding about $290 billion annually to the nation's health care spending.

Click here to read about the study findings.

No comments:

Post a Comment